Fendov 1250 avec Systamex, dispositif intraruminal à libération séquentielle pour bovins
Fendov 1250 avec Systamex, dispositif intraruminal à libération séquentielle pour bovins
Authorised
- Oxfendazole
Product identification
Medicine name:
Fendov 1250 avec Systamex, dispositif intraruminal à libération séquentielle pour bovins
Active substance:
- Oxfendazole
Target species:
-
Cattle
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Oxfendazole1250.00/milligram(s)1.00Dose
Pharmaceutical form:
-
Pulsatile-release intraruminal device
Withdrawal period by route of administration:
-
Oral use
- Cattle
-
Meat and offal7month
-
Milkno withdrawal periodDo not use in animals producing milk for human consumption
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP52AC02
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Luxembourg
Package description:
- Fendov 1250 avec Systamex 12 Container Pulsatile-release intraruminal device
- Fendov 1250 avec Systamex 24 Container Pulsatile-release intraruminal device
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Zoetis Belgium
Marketing authorisation date:
Manufacturing sites for batch release:
- Zoetis Belgium
Responsible authority:
- Le Ministère De La Santé Division De La Pharmacie Et Des Médicaments
Authorisation number:
- V 087/91/11/0335
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 16/03/2023
How useful was this page?:
